Chemotherapy in chronic kidney disease and dialysis
S Karam, V Gutgarts, I Glezerman - Onco-Nephrology, 2019 - experts.umn.edu
S Karam, V Gutgarts, I Glezerman
Onco-Nephrology, 2019•experts.umn.eduThis chapter will review available evidence for management of patients with chronic kidney
disease and end-stage renal disease who are undergoing anticancer therapy. Both
conventional chemotherapy and targeted biological therapies will be reviewed with respect
to safety and necessary dose adjustments, to account for the reduced kidney function in this
population of patients.
disease and end-stage renal disease who are undergoing anticancer therapy. Both
conventional chemotherapy and targeted biological therapies will be reviewed with respect
to safety and necessary dose adjustments, to account for the reduced kidney function in this
population of patients.
Abstract
This chapter will review available evidence for management of patients with chronic kidney disease and end-stage renal disease who are undergoing anticancer therapy. Both conventional chemotherapy and targeted biological therapies will be reviewed with respect to safety and necessary dose adjustments, to account for the reduced kidney function in this population of patients.
experts.umn.edu
以上显示的是最相近的搜索结果。 查看全部搜索结果